Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford Medical Alumni Network

Sign up for mailings - keep in touch with medicine at Oxford.

Update your detailsMake sure you receive alumni news and event invitations.

Medical Sciences Division News

Brain cells critical for mouse navigation found to be highly specialised

Researchers from the Department of Pharmacology have found that the ‘neural compass’ that enables mice to navigate is formed of specialised brain cells that respond in different ways to stimuli such as light and sound.

First trial of vaccine to prevent Lynch syndrome-associated cancers approved to start in Oxford

Phase 1 of the INTERCEPT-Lynch trial, which is funded by Moderna, sponsored by the University of Oxford and run by the University's Oncology Clinical Trials Office with support from Oxford Cancer, has received authorisation from the Medicines and Healthcare products Regulatory Agency and is expected to begin recruiting participants this summer.

Oxford joins major new Educational Neuroscience centre to shape government policy

Professor Gaia Scerif from the Department of Experimental Psychology is a key partner in a newly announced research centre that will help shape education policy across England.

Exosomes are more diverse than we previously thought: implications for disease diagnosis and management

A new opinion article published in Trends in Cell Biology explores how tiny packages released by cells, known as exosomes, could help researchers better understand disease and may one day support new approaches to diagnosis and treatment.

Pioneering study sets out to answer and address why osteoarthritis impacts patients differently

Researchers from the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) are playing leading roles in a major new UK-wide research consortium aiming to improve treatment and outcomes for people living with osteoarthritis.